Windlas founder exits board for Rs 1.56 crore President role

Windlas Biotech Limited said founder Ashok Kumar Windlass left its board at 10.00 a.m. on November 5, 2026 and is proposed to become Founder President from November 6 on fixed annual remuneration of Rs 1.56 crore, subject to shareholder approval. The board described the transition as part of long-term succession planning.

What changed in Windlas's leadership structure?

Ashok Kumar Windlass ceased to be Whole-time Director and Director of Windlas on November 5, 2026 at 10.00 a.m. The board accepted his resignation at its meeting on the same date, and he also ceased to be a member of the Corporate Social Responsibility Committee. In his November 5 resignation letter, he cited long-term succession planning and his wish to step down from the board, confirming that there were no other material reasons.

The board approved his appointment as Founder President and Senior Management Personnel from November 6, 2026, subject to shareholder approval. This keeps Ashok Kumar Windlass in a senior management role while ending his directorship. The filing says he was appointed Managing Director on April 1, 2001, became Whole-time Director on May 3, 2021, and has more than 56 years of experience in manufacturing and pharmaceuticals.

Why does the Windlas Founder President role need approval?

The proposed Founder President appointment requires shareholder approval because Windlas treats it as an office or place of profit under Section 188(1)(f) of the Companies Act, 2013. The board approved the appointment after recommendations from its Nomination and Remuneration Committee and Audit Committee on November 5, 2026.

Windlas fixed Ashok Kumar Windlass's remuneration at Rs 1.56 crore a year, with no increase over the remuneration he last drew as Whole-time Director. The company said his institutional knowledge, strategic insight, industry expertise and leadership capabilities are expected to continue benefiting Windlas. The filing does not disclose the shareholder-meeting date, tenure, performance-linked pay or a revised compensation mix.

The new position is senior management rather than a board role, which distinguishes it from the directorship that ended on November 5. Ashok Kumar Windlass remains a promoter and founder, and the filing records his holding at 44,00,000 shares. The company has not stated that the appointment changes that shareholding.

Who is now Chairman of the Windlas board?

Hitesh Windlass became Chairman of the Windlas board on November 5, 2026 while continuing as Managing Director. The board approved the additional chairmanship on the same day it accepted Ashok Kumar Windlass's resignation, putting the board transition and the founder's management appointment into one succession process.

Hitesh Windlass joined Windlas on January 21, 2008 and has been Managing Director since April 30, 2020. Windlas says he has more than 18 years of management experience and has set up its Domestic Trade Generics, OTC Brands and Exports strategic business verticals. His stated responsibilities include technical operations, quality, research and development, manufacturing strategy and financial strategy.

The disclosure identifies Ashok Kumar Windlass as Hitesh Windlass's father and Manoj Kumar Windlass, Joint Managing Director, as Hitesh Windlass's brother. It also identifies Non-Executive Director Prachi Jain Windlass as Ashok Kumar Windlass's daughter-in-law. Windlas said Hitesh Windlass was not debarred from holding directorial office by an order of the Securities and Exchange Board of India or another authority.

How did Windlas perform in the September 2026 quarter?

Windlas reported revenue from operations of Rs 263.908 crore for the quarter ended September 30, 2026, up from Rs 222.398 crore in the quarter ended September 30, 2025. Profit for the quarter rose to Rs 18.052 crore from Rs 17.800 crore, while profit before tax declined to Rs 23.300 crore from Rs 23.588 crore.

For the six months ended September 30, 2026, revenue from operations increased to Rs 512.007 crore from Rs 432.488 crore in the corresponding 2025 period. Six-month profit was Rs 35.705 crore, compared with Rs 35.465 crore a year earlier, while profit before tax declined to Rs 46.236 crore from Rs 46.846 crore. Windlas reports pharmaceuticals as its one primarily reportable segment.

Costs rose during the six-month comparison. Material consumed increased to Rs 352.912 crore from Rs 269.741 crore, and employee benefit expense rose to Rs 92.248 crore from Rs 68.676 crore. Windlas also recognised employee share-based payment expense of Rs 14.058 crore for the six months, compared with Rs 1.935 crore in the prior-year period.

What other corporate actions did Windlas disclose?

Windlas completed a tender-offer buyback of 4,70,000 fully paid-up equity shares at Rs 1,000 each, aggregating Rs 47 crore, following the April 17, 2026 board resolution. Its issued, subscribed and paid-up share capital consequently reduced to 2,06,36,229 equity shares with a face value of Rs 5 each. Equity share capital was Rs 10.318 crore on September 30, 2026, versus Rs 10.553 crore on March 31, 2026.

Windlas also disclosed that Windlas Inc., USA, its wholly owned non-operating subsidiary, was dissolved effective March 31, 2026. The dissolution followed a February 5, 2026 board resolution and a filing with the Delaware Division of Corporations. From April 1, 2026, Windlas is no longer required to prepare consolidated financial statements; the statutory auditor did not modify its limited-review conclusion in respect of that matter.

The September 2026 half-year cash flow statement recorded Rs 53.479 crore of net cash from operating activities, compared with Rs 55.890 crore in the September 2025 period. Net cash used in financing activities was Rs 50.200 crore, including Rs 47.997 crore for the share buyback and Rs 13.001 crore of dividend paid.

Conclusion

Windlas has formalised a founder-led succession change: Ashok Kumar Windlass has exited the board and the Corporate Social Responsibility Committee, while Hitesh Windlass has assumed the chairmanship alongside his Managing Director role. The founder is intended to remain in senior management as Founder President on unchanged fixed annual remuneration of Rs 1.56 crore.

The next disclosed matter to watch is shareholder approval for the Founder President appointment, which Windlas classifies as an office or place of profit under Section 188(1)(f). The filing does not give a voting date, so a future company communication will be needed to confirm whether the November 6, 2026 appointment becomes effective on the proposed terms.